Deosen Biochemical (Ordos) Ltd. is a leading national high-tech enterprise specializing in the R&D, production, sales, and technical services of hydrocolloids. The company, founded in 1992, has garnered significant recognition within its industry, having been awarded "China Top 100 Light Industry Enterprises" in 2016 and named "Inner Mongolia Top 100 Brands" at the 5th Brands Conference of Inner Mongolia in 2018. With a primary focus on Xanthan gum, developed using proprietary technology, Deosen Biochemical boasts prominent brands including Ziboxan and Zibozan. Within the hydrocolloids market, Deosen has firmly established its position, holding the largest global market share for several years and securing multiple science and technology awards from various local and national bodies, including the China Food Additives Association certification (ISO9001, ISO22000, IP, BRC, HALAL, KOSHER, etc.). In terms of investments, Deosen Biochemical received a Venture Round investment on 01 January 2000, with participation from Comway Capital. The company's operational base is headquartered in China. Deosen Biochemical stands as a notable player in the manufacturing industry, leveraging its expertise and market dominance in the hydrocolloids sector.
No recent news or press coverage available for Deosen Biochemical(Ordos)Ltd..